US Air Force  

Air Force Public Health

Total Force Integration

Integrity Service Excellence


USAF -- Public Health Information and Resources

Home ANG Specific Resources Arthropod-Borne Diseases Arthropod Taxonomy CBRNE
Communicable and Pandemic Diseases
Deployment Medicine Disease Surveillance Epidemiology
Force Health Management
Food-Borne Illnesses Hearing Conservation Helminthology Infectious Diseases Medical Entomology
Medical Intelligence Occupational Health Parasitology PDHRA
PH Officer
  PH Technician   Travelers' Health Tropical Medicine Zoonotic Diseases
Microsoft Office Tutorials
Palm OS Resources
 

Allergic Sensitivities

Arthropod Infestations

Bacterial Diseases

Bites and Scratches

Cestode Zoonoses

Fungal Infections

Nematode Zoonoses

Protozoan Diseases

Rickettsial Diseases

Trematode Zoonosis

Viral Diseases

Zoonotic Diseases


Bacterial Diseases - BLASTOMYCOSIS

SYNONYMS:
North American blastomycosis, Chicago disease, Gilchrist's disease.
ETIOLOGY:
Blastomyces dermatitidis, a dimorphic fungus existing in mycelial form in cultures and as a budding yeast in the tissues of infected mammals.
GEOGRAPHIC DISTRIBUTION:
The disease has been observed in the United States, eastern Canada, Zaire, Tanzania, South Africa, and Tunisia. Autochthonous cases may have occurred in some Latin American countries.
THE DISEASE IN MAN:
The incubation period is not well known; it possibly extends to several weeks or months. Blastomycosis is a chronic disease that principally affects the lungs. The respiratory symptomatology initially resembles influenzas purulent or bloody expectoration, weight loss, and cachexia, in addition to fever and cough, may develop later. If the infection remains localized, it can become asymptomatic. When it disseminates, it can cause subcutaneous abscesses as well as localized infections in several organs. Death frequently results in cases of untreated disseminated infection. The cutaneous form is commonly secondary to the pulmo-nary and is characterized by an irregular-shaped, scabby ulcer that has raised borders and contains minute abscesses. Lesions develop on exposed parts of the body.
THE DISEASE IN ANIMALS:
The highest incidence is observed in dogs around 2 years of age. The symptoms consist of weight loss, chronic cough, dyspnea, cutaneous abscesses, fever, anorexia, and sometimes blindness. The lesions localize in the lungs, lymph nodes, eyes, skin, and joints and bones. Of 47 clinical cases recently described, 72% occurred in large males. There were lesions of the respiratory tract in 85% of the cases.
SOURCE OF INFECTION AND MODE OF TRANSMISSION:
The reservoir is environmental, probably the soil, but the ecologic biotope has not been determined. Transmission to man and to animals is effected by aerosols; the fungal conidia are the infecting element. Persons at highest risk are those having the most contact with the soil. Dogs most frequently infected are sporting and hunting breeds.
ROLE OF ANIMALS IN THE EPIDEMIOLOGY OF THE DISEASE:
None. It is a disease common to man and animals. Cases of transmission from individual to individual (man or animal) are not known.
DIAGNOSIS:
Diagnosis is based on direct microscopic examination of sputum and material from lesions, on isolation of the agent in culture media, and on examination of histologic preparations. B. dermatitidis grows well in Sabouraud's culture medium or other adequate median it is most distinctive in its sprouting yeast form, and therefore the inoculated medium should be incubated at 37oC, since at ambient temperature the mycelial form of the fungus is obtained. B. dermatitidis in its yeast form (in tissues or cultures at 37oC) is characterized by a single bud attached to the parent cell by a wide base, from which it detaches when it has reached a size similar to the parent cell. In contrast, Paracoccidioides brasiliensis, the agent of paracoccidioidomycosis ("South American blastomycosis"), has multiple buds in the yeast phase. Serologic tests in use are complement fixation and gel immunodiffusion; the latter gives better results. It should be borne in mind that cross-reactions with Histoplasma and Coccidioides may occur. At present, the intradermal test is considered to have no diagnostic value.
TREATMENT: Humans.
Itraconazole, 100-200 mg/d orally, is now the therapy of choice for nonmeningeal disease, with a response rate of over 70%. Amphotericin B is given for treatment failures or cases with central nervous system involvement. Follow-up for relapse should be regularly made for several years so that therapy may be resumed or another drug instituted. Animals. Rare primary cutaneous disease may persist for months; these lesions should be removed surgically since blastomycosis responds poorly to therapy. Amphotericin B is considered the drug of choice, but treatment is of little avail once the disease is disseminated. The combination of amphotericin B and ketoconazole has been suggested to reduce the rate of relapse.
CONTROL:
As long as the ecologic biotope remains poorly defined, practical prevention methods cannot be established.